MUMBAI, March 31 (Reuters) - Indian biotechnology firm Biocon Ltd could file a prospectus for a share listing for its research services business arm Syngene International (IPO-SYNN.NS) within the next two months, two sources directly involved in the process said.
The IPO could fetch up to 10 billion rupees ($159.8 million), said one of the sources. However, the sources did not specify how much was being sold in Syngene. Biocon had said in January it was looking to sell up to 15 percent of its stake via an IPO.
09:14 Airbus seeks new talks with European nations over A400M costs15
07:15 Telefonica to sell up to 40 percent of Telxius to KKR for 1.3 billion euros19
14:29 Unilever rejects $143 billion Kraft Heinz bid as without merit20
12:33 Kraft Heinz to pursue merger despite Unilever rejection19